{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T22:33:13Z","timestamp":1781735593633,"version":"3.54.5"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,2]]},"DOI":"10.7759\/cureus.44583","type":"journal-article","created":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T21:30:45Z","timestamp":1693690245000},"source":"Crossref","is-referenced-by-count":6,"title":["Iatrogenic Side Effects of Pain Therapies"],"prefix":"10.7759","author":[{"given":"Christopher","family":"Gharibo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asbj\u00f8rn M","family":"Drewes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Breve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Rekatsina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Antonio","family":"Narvaez Tamayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giustino","family":"Varrassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Paladini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2017.11.030","article-title":"Overdose and adverse drug event experiences among adult patients in the emergency department","volume":"86","author":"Bohnert AS","year":"2018","unstructured":"Bohnert AS, Walton MA, Cunningham RM, Ilgen MA, Barry K, Chermack ST, Blow FC. Overdose and adverse drug event experiences among adult patients in the emergency department. Addict Behav. 2018, 86:66-72. 10.1016\/j.addbeh.2017.11.030","journal-title":"Addict Behav"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1533-2500.2008.00204.x","article-title":"Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone)","volume":"8","author":"Pergolizzi J","year":"2008","unstructured":"Pergolizzi J, B\u00f6ger RH, Budd K, et al.. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract. 2008, 8:287-313. 10.1111\/j.1533-2500.2008.00204.x","journal-title":"Pain Pract"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s10354-021-00903-0","article-title":"Polypharmacy in elderly people","volume":"172","author":"Dovjak P","year":"2022","unstructured":"Dovjak P. Polypharmacy in elderly people. Wien Med Wochenschr. 2022, 172:109-13. 10.1007\/s10354-021-00903-0","journal-title":"Wien Med Wochenschr"},{"key":"ref4","article-title":"Epidural interventions in the management of chronic spinal pain: American Society of Interventional Pain Physicians (ASIPP) Comprehensive Evidence-Based Guidelines","volume":"24(S1)","author":"Manchikanti L","year":"2021","unstructured":"Manchikanti L, Knezevic NN, Navani A, et al.. Epidural interventions in the management of chronic spinal pain: American Society of Interventional Pain Physicians (ASIPP) Comprehensive Evidence-Based Guidelines. Pain Physician. 2021, 24(S1):27-208.","journal-title":"Pain Physician"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e31820fc7f2","article-title":"Injury and liability associated with cervical procedures for chronic pain","volume":"114","author":"Rathmell JP","year":"2011","unstructured":"Rathmell JP, Michna E, Fitzgibbon DR, Stephens LS, Posner KL, Domino KB. Injury and liability associated with cervical procedures for chronic pain. Anesthesiology. 2011, 114:918-26. 10.1097\/ALN.0b013e31820fc7f2","journal-title":"Anesthesiology"},{"key":"ref6","article-title":"Do the gaps in the ligamentum flavum in the cervical spine translate into dural punctures? An analysis of 4,396 fluoroscopic interlaminar epidural injections","volume":"18","author":"Manchikanti L","year":"2015","unstructured":"Manchikanti L, Malla Y, Cash KA, et al.. Do the gaps in the ligamentum flavum in the cervical spine translate into dural punctures? An analysis of 4,396 fluoroscopic interlaminar epidural injections. Pain Physician. 2015, 18:259-66.","journal-title":"Pain Physician"},{"key":"ref7","article-title":"Transforaminal epidural steroid injections: a systematic review and meta-analysis of efficacy and safety","volume":"24","author":"Helm Ii S","year":"2021","unstructured":"Helm Ii S, Harmon PC, Noe C, Calodney AK, Abd-Elsayed A, Knezevic NN, Racz GB. Transforaminal epidural steroid injections: a systematic review and meta-analysis of efficacy and safety. Pain Physician. 2021, 24:S209-32.","journal-title":"Pain Physician"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/2152-7806.120784","article-title":"A blunt needle (Epimed(\u00ae)) does not eliminate the risk of vascular penetration during transforaminal epidural injection","volume":"4","author":"Ilkhchoui Y","year":"2013","unstructured":"Ilkhchoui Y, Koshkin E. A blunt needle (Epimed(\u00ae)) does not eliminate the risk of vascular penetration during transforaminal epidural injection. Surg Neurol Int. 2013, 4:S404-6. 10.4103\/2152-7806.120784","journal-title":"Surg Neurol Int"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.5505\/agri.2012.88700","article-title":"Comparison of blunt and sharp needles for transforaminal epidural steroid injections","volume":"24","author":"\u00d6zcan U","year":"2012","unstructured":"\u00d6zcan U, \u015eahin \u015e, Gurbet A, T\u00fcrker G, \u00d6zg\u00fcr M, \u00c7elebi S. Comparison of blunt and sharp needles for transforaminal epidural steroid injections. Agri. 2012, 24:85-9. 10.5505\/agri.2012.88700","journal-title":"Agri"},{"key":"ref10","article-title":"Comparison of intravascular injection rate between blunt and sharp needles during cervical transforaminal epidural block","volume":"2019","author":"Jeon Y","unstructured":"Jeon Y, Lee J, Shin H, et al.. Comparison of intravascular injection rate between blunt and sharp needles during cervical transforaminal epidural block. Pain Physician. 2019:265-70.","journal-title":"Pain Physician"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2016.1184246","article-title":"Safety of epidural steroid injections","volume":"15","author":"Schneider B","year":"2016","unstructured":"Schneider B, Zheng P, Mattie R, Kennedy DJ. Safety of epidural steroid injections. Expert Opin Drug Saf. 2016, 15:1031-9. 10.1080\/14740338.2016.1184246","journal-title":"Expert Opin Drug Saf"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1017\/dmp.2017.32","article-title":"Epidemiological effectiveness and cost of a fungal meningitis outbreak response in New River Valley, Virginia: local health department and clinical perspectives","volume":"12","author":"Dorratoltaj N","year":"2018","unstructured":"Dorratoltaj N, O'Dell ML, Bordwine P, Kerkering TM, Redican KJ, Abbas KM. Epidemiological effectiveness and cost of a fungal meningitis outbreak response in New River Valley, Virginia: local health department and clinical perspectives. Disaster Med Public Health Prep. 2018, 12:38-46. 10.1017\/dmp.2017.32","journal-title":"Disaster Med Public Health Prep"},{"key":"ref13","article-title":"Conus medullaris infarction after a right L4 transforaminal epidural steroid injection using dexamethasone","volume":"19","author":"Gharibo CG","year":"2016","unstructured":"Gharibo CG, Fakhry M, Diwan S, et al.. Conus medullaris infarction after a right L4 transforaminal epidural steroid injection using dexamethasone. Pain Physician. 2016, 19:1211-4.","journal-title":"Pain Physician"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-022-00936-y","article-title":"The options for neuraxial drug administration","volume":"36","author":"Hermanns H","year":"2022","unstructured":"Hermanns H, Bos EM, van Zuylen ML, Hollmann MW, Stevens MF. The options for neuraxial drug administration. CNS Drugs. 2022, 36:877-96. 10.1007\/s40263-022-00936-y","journal-title":"CNS Drugs"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aei133","article-title":"Incidence of lower thoracic ligamentum flavum midline gaps","volume":"94","author":"Lirk P","year":"2005","unstructured":"Lirk P, Colvin J, Steger B, et al.. Incidence of lower thoracic ligamentum flavum midline gaps. Br J Anaesth. 2005, 94:852-5. 10.1093\/bja\/aei133","journal-title":"Br J Anaesth"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/00001503-200410000-00015","article-title":"Recent insights into the pharmacokinetics of spinal opioids and the relevance to opioid selection","volume":"17","author":"Bernards CM","year":"2004","unstructured":"Bernards CM. Recent insights into the pharmacokinetics of spinal opioids and the relevance to opioid selection. Curr Opin Anaesthesiol. 2004, 17:441-7. 10.1097\/00001503-200410000-00015","journal-title":"Curr Opin Anaesthesiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200312000-00023","article-title":"Cervical and high thoracic ligamentum flavum frequently fails to fuse in the midline","volume":"99","author":"Lirk P","year":"2003","unstructured":"Lirk P, Kolbitsch C, Putz G, et al.. Cervical and high thoracic ligamentum flavum frequently fails to fuse in the midline. Anesthesiology. 2003, 99:1387-90. 10.1097\/00000542-200312000-00023","journal-title":"Anesthesiology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4065\/79.5.682","article-title":"Epidural abscess and meningitis after epidural corticosteroid injection","volume":"79","author":"Hooten WM","year":"2004","unstructured":"Hooten WM, Kinney MO, Huntoon MA. Epidural abscess and meningitis after epidural corticosteroid injection. Mayo Clin Proc. 2004, 79:682-6. 10.4065\/79.5.682","journal-title":"Mayo Clin Proc"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra055111","article-title":"Spinal epidural abscess","volume":"355","author":"Darouiche RO","year":"2006","unstructured":"Darouiche RO. Spinal epidural abscess. N Engl J Med. 2006, 355:2012-20. 10.1056\/NEJMra055111","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2005.05.032","article-title":"Iatrogenic (para-) spinal abscesses and meningitis following injection therapy for low back pain","volume":"116","author":"Gaul C","year":"2005","unstructured":"Gaul C, Neund\u00f6rfer B, Winterholler M. Iatrogenic (para-) spinal abscesses and meningitis following injection therapy for low back pain. Pain. 2005, 116:407-10. 10.1016\/j.pain.2005.05.032","journal-title":"Pain"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.06.008","article-title":"Spinal cord infarction: clinical and radiological features","volume":"27","author":"Yadav N","year":"2018","unstructured":"Yadav N, Pendharkar H, Kulkarni GB. Spinal cord infarction: clinical and radiological features. J Stroke Cerebrovasc Dis. 2018, 27:2810-21. 10.1016\/j.jstrokecerebrovasdis.2018.06.008","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.4103\/0028-3886.250703","article-title":"Injection-related iatrogenic peripheral nerve injuries: surgical experience of 354 operated cases","volume":"67","author":"Desai K","year":"2019","unstructured":"Desai K, Warade AC, Jha AK, Pattankar S. Injection-related iatrogenic peripheral nerve injuries: surgical experience of 354 operated cases. Neurol India. 2019, 67:S82-91. 10.4103\/0028-3886.250703","journal-title":"Neurol India"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.15520\/jcmro.v4i02.382","article-title":"Pharmacological management of chronic pain: how to deal with the Catch-22 situation","volume":"4","author":"Andresen T","year":"2021","unstructured":"Andresen T, Niesters M, Dahan A, et al.. Pharmacological management of chronic pain: how to deal with the Catch-22 situation. J Curr Med Res Opin. 2021, 4: 773\u221292. 10.15520\/jcmro.v4i02.382","journal-title":"J Curr Med Res Opin"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-018-0094-9","article-title":"A pharmacological rationale to reduce the incidence of opioid induced tolerance and hyperalgesia: a review","volume":"7","author":"Varrassi G","year":"2018","unstructured":"Varrassi G, Fusco M, Skaper SD, et al.. A pharmacological rationale to reduce the incidence of opioid induced tolerance and hyperalgesia: a review. Pain Ther. 2018, 7:59-75. 10.1007\/s40122-018-0094-9","journal-title":"Pain Ther"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206914","article-title":"Paracetamol: not as safe as we thought? A systematic literature review of observational studies","volume":"75","author":"Roberts E","year":"2016","unstructured":"Roberts E, Delgado Nunes V, Buckner S, et al.. Paracetamol: not as safe as we thought? A systematic literature review of observational studies. Ann Rheum Dis. 2016, 75:552-9. 10.1136\/annrheumdis-2014-206914","journal-title":"Ann Rheum Dis"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2018.1429793","article-title":"Gastrointestinal safety and tolerability of oral non-aspirin over-the-counter analgesics","volume":"130","author":"Moore N","year":"2018","unstructured":"Moore N, Scheiman JM. Gastrointestinal safety and tolerability of oral non-aspirin over-the-counter analgesics. Postgrad Med. 2018, 130:188-99. 10.1080\/00325481.2018.1429793","journal-title":"Postgrad Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2010.02966.x","article-title":"The adverse event profile of pregabalin: a systematic review and meta-analysis of randomized controlled trials","volume":"52","author":"Zaccara G","year":"2011","unstructured":"Zaccara G, Gangemi P, Perucca P, Specchio L. The adverse event profile of pregabalin: a systematic review and meta-analysis of randomized controlled trials. Epilepsia. 2011, 52:826-36. 10.1111\/j.1528-1167.2010.02966.x","journal-title":"Epilepsia"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1177\/2050640618818305","article-title":"Pathophysiology and management of opioid-induced constipation: European expert consensus statement","volume":"7","author":"Farmer AD","year":"2019","unstructured":"Farmer AD, Drewes AM, Chiarioni G, De Giorgio R, O'Brien T, Morlion B, Tack J. Pathophysiology and management of opioid-induced constipation: European expert consensus statement. United European Gastroenterol J. 2019, 7:7-20. 10.1177\/2050640618818305","journal-title":"United European Gastroenterol J"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.26628","article-title":"MRI analysis of fecal volume and dryness: validation study using an experimental oxycodone-induced constipation model","volume":"50","author":"Mark EB","year":"2019","unstructured":"Mark EB, B\u00f8dker MB, Gr\u00f8nlund D, \u00d8stergaard LR, Fr\u00f8kjaer JB, Drewes AM. MRI analysis of fecal volume and dryness: validation study using an experimental oxycodone-induced constipation model. J Magn Reson Imaging. 2019, 50:733-45. 10.1002\/jmri.26628","journal-title":"J Magn Reson Imaging"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.16.2.181","article-title":"Treatment of opioid-induced gut dysfunction","volume":"16","author":"Holzer P","year":"2007","unstructured":"Holzer P. Treatment of opioid-induced gut dysfunction. Expert Opin Investig Drugs. 2007, 16:181-94. 10.1517\/13543784.16.2.181","journal-title":"Expert Opin Investig Drugs"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1185\/03007991003689175","article-title":"Pharmacological treatment of chronic pain - the need for CHANGE","volume":"26","author":"Varrassi G","year":"2010","unstructured":"Varrassi G, M\u00fcller-Schwefe G, Pergolizzi J, et al.. Pharmacological treatment of chronic pain - the need for CHANGE. Curr Med Res Opin. 2010, 26:1231-45. 10.1185\/03007991003689175","journal-title":"Curr Med Res Opin"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S318564","article-title":"Common clinical practice for opioid-induced constipation: a physician survey","volume":"14","author":"Coluzzi F","year":"2021","unstructured":"Coluzzi F, Alvaro D, Caraceni AT, et al.. Common clinical practice for opioid-induced constipation: a physician survey. J Pain Res. 2021, 14:2255-64. 10.2147\/JPR.S318564","journal-title":"J Pain Res"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.30","article-title":"Opioid-induced constipation: challenges and therapeutic opportunities","volume":"106","author":"Camilleri M","year":"2011","unstructured":"Camilleri M. Opioid-induced constipation: challenges and therapeutic opportunities. Am J Gastroenterol. 2011, 106:835-42; quiz 843. 10.1038\/ajg.2011.30","journal-title":"Am J Gastroenterol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1177\/2050640618786145","article-title":"The patient burden of opioid-induced constipation: new insights from a large, multinational survey in five European countries","volume":"6","author":"Andresen V","year":"2018","unstructured":"Andresen V, Banerji V, Hall G, Lass A, Emmanuel AV. The patient burden of opioid-induced constipation: new insights from a large, multinational survey in five European countries. United European Gastroenterol J. 2018, 6:1254-66. 10.1177\/2050640618786145","journal-title":"United European Gastroenterol J"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2012.657301","article-title":"The Bowel Function Index: a new validated scale for assessing opioid-induced constipation","volume":"28","author":"Ducrott\u00e9 P","year":"2012","unstructured":"Ducrott\u00e9 P, Causs\u00e9 C. The Bowel Function Index: a new validated scale for assessing opioid-induced constipation. Curr Med Res Opin. 2012, 28:457-66. 10.1185\/03007995.2012.657301","journal-title":"Curr Med Res Opin"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1111\/pme.12911","article-title":"Opioid-induced constipation","volume":"16 Suppl 1","author":"Webster LR","year":"2015","unstructured":"Webster LR. Opioid-induced constipation. Pain Med. 2015, 16 Suppl 1:S16-21. 10.1111\/pme.12911","journal-title":"Pain Med"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.5114\/wo.2012.28792","article-title":"The impact of opioid analgesics on the gastrointestinal tract function and the current management possibilities","volume":"16","author":"Leppert W","year":"2012","unstructured":"Leppert W. The impact of opioid analgesics on the gastrointestinal tract function and the current management possibilities. Contemp Oncol (Pozn). 2012, 16:125-31. 10.5114\/wo.2012.28792","journal-title":"Contemp Oncol (Pozn)"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2018.02.008","article-title":"The impact of naloxegol on anal sphincter function - using a human experimental model of opioid-induced bowel dysfunction","volume":"117","author":"Gr\u00f8nlund D","year":"2018","unstructured":"Gr\u00f8nlund D, Poulsen JL, Krogh K, et al.. The impact of naloxegol on anal sphincter function - using a human experimental model of opioid-induced bowel dysfunction. Eur J Pharm Sci. 2018, 117:187-92. 10.1016\/j.ejps.2018.02.008","journal-title":"Eur J Pharm Sci"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-017-4784-7","article-title":"Prolonged-release oxycodone\/naloxone improves anal sphincter relaxation compared to oxycodone plus macrogol 3350","volume":"62","author":"Poulsen JL","year":"2017","unstructured":"Poulsen JL, Brock C, Gr\u00f8nlund D, Liao D, Gregersen H, Krogh K, Drewes AM. Prolonged-release oxycodone\/naloxone improves anal sphincter relaxation compared to oxycodone plus macrogol 3350. Dig Dis Sci. 2017, 62:3156-66. 10.1007\/s10620-017-4784-7","journal-title":"Dig Dis Sci"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-022-00392-y","article-title":"A survey of the incidence of constipation in patients with chronic non-cancer pain using opioid analgesics in Japan","volume":"11","author":"Sonohata M","year":"2022","unstructured":"Sonohata M, Wada S, Koretaka Y, Morioka Y, Mishima H, Mawatari M. A survey of the incidence of constipation in patients with chronic non-cancer pain using opioid analgesics in Japan. Pain Ther. 2022, 11:845-59. 10.1007\/s40122-022-00392-y","journal-title":"Pain Ther"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3344\/kjp.2019.32.2.69","article-title":"Opioid-induced constipation: a narrative review of therapeutic options in clinical management","volume":"32","author":"Lang-Illievich K","year":"2019","unstructured":"Lang-Illievich K, Bornemann-Cimenti H. Opioid-induced constipation: a narrative review of therapeutic options in clinical management. Korean J Pain. 2019, 32:69-78. 10.3344\/kjp.2019.32.2.69","journal-title":"Korean J Pain"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1007\/s00482-014-1452-0","article-title":"[Long-term opioid therapy in chronic noncancer pain. A systematic review and meta-analysis of efficacy, tolerability and safety in open-label extension trials with study duration of at least 26 weeks]","volume":"29","author":"H\u00e4user W","year":"2015","unstructured":"H\u00e4user W, Bernardy K, Maier C. [Long-term opioid therapy in chronic noncancer pain. A systematic review and meta-analysis of efficacy, tolerability and safety in open-label extension trials with study duration of at least 26 weeks]. Schmerz. 2015, 29:96-108. 10.1007\/s00482-014-1452-0","journal-title":"Schmerz"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2008.00495.x","article-title":"The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1)","volume":"10","author":"Bell TJ","year":"2009","unstructured":"Bell TJ, Panchal SJ, Miaskowski C, Bolge SC, Milanova T, Williamson R. The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1). Pain Med. 2009, 10:35-42. 10.1111\/j.1526-4637.2008.00495.x","journal-title":"Pain Med"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-021-00271-y","article-title":"Impact and consequences of opioid-induced constipation: a survey of patients","volume":"10","author":"Varrassi G","year":"2021","unstructured":"Varrassi G, Banerji V, Gianni W, Marinangeli F, Pinto C. Impact and consequences of opioid-induced constipation: a survey of patients. Pain Ther. 2021, 10:1139-53. 10.1007\/s40122-021-00271-y","journal-title":"Pain Ther"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.5056\/jnm15175","article-title":"The impact of opioid treatment on regional gastrointestinal transit","volume":"22","author":"Poulsen JL","year":"2016","unstructured":"Poulsen JL, Nilsson M, Brock C, Sandberg TH, Krogh K, Drewes AM. The impact of opioid treatment on regional gastrointestinal transit. J Neurogastroenterol Motil. 2016, 22:282-91. 10.5056\/jnm15175","journal-title":"J Neurogastroenterol Motil"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2007.01415.x","article-title":"Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden","volume":"61","author":"Panchal SJ","year":"2007","unstructured":"Panchal SJ, M\u00fcller-Schwefe P, Wurzelmann JI. Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden. Int J Clin Pract. 2007, 61:1181-7. 10.1111\/j.1742-1241.2007.01415.x","journal-title":"Int J Clin Pract"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.03238.x","article-title":"Chronic constipation: a survey of the patient perspective","volume":"25","author":"Johanson JF","year":"2007","unstructured":"Johanson JF, Kralstein J. Chronic constipation: a survey of the patient perspective. Aliment Pharmacol Ther. 2007, 25:599-608. 10.1111\/j.1365-2036.2006.03238.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2009.01458.x","article-title":"Opioid-induced bowel disorders and narcotic bowel syndrome in patients with chronic non-cancer pain","volume":"22","author":"Tuteja AK","year":"2010","unstructured":"Tuteja AK, Biskupiak J, Stoddard GJ, Lipman AG. Opioid-induced bowel disorders and narcotic bowel syndrome in patients with chronic non-cancer pain. Neurogastroenterol Motil. 2010, 22:424-30, e96. 10.1111\/j.1365-2982.2009.01458.x","journal-title":"Neurogastroenterol Motil"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2016.00131","article-title":"Opioid-induced constipation among a convenience sample of patients with cancer pain","volume":"6","author":"Coyne KS","year":"2016","unstructured":"Coyne KS, Sexton C, LoCasale RJ, King FR, Margolis MK, Ahmedzai SH. Opioid-induced constipation among a convenience sample of patients with cancer pain. Front Oncol. 2016, 6:131. 10.3389\/fonc.2016.00131","journal-title":"Front Oncol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph192013354","article-title":"Oxycodone-naloxone combination hinders opioid consumption in osteoarthritic chronic low back pain: a retrospective study with two years of follow-up","volume":"19","author":"Polati E","year":"2022","unstructured":"Polati E, Nizzero M, Rama J, et al.. Oxycodone-naloxone combination hinders opioid consumption in osteoarthritic chronic low back pain: a retrospective study with two years of follow-up. Int J Environ Res Public Health. 2022, 19:10.3390\/ijerph192013354","journal-title":"Int J Environ Res Public Health"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-020-00195-z","article-title":"What to do and what not to do in the management of opioid-induced constipation: a choosing wisely report","volume":"9","author":"Alvaro D","year":"2020","unstructured":"Alvaro D, Caraceni AT, Coluzzi F, et al.. What to do and what not to do in the management of opioid-induced constipation: a choosing wisely report. Pain Ther. 2020, 9:657-67. 10.1007\/s40122-020-00195-z","journal-title":"Pain Ther"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-022-00354-4","article-title":"Opioid-induced constipation in real-world practice: a physician survey, 1 year later","volume":"11","author":"Alvaro D","year":"2022","unstructured":"Alvaro D, Coluzzi F, Gianni W, et al.. Opioid-induced constipation in real-world practice: a physician survey, 1 year later. Pain Ther. 2022, 11:477-91. 10.1007\/s40122-022-00354-4","journal-title":"Pain Ther"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.16201","article-title":"Efficacy and safety of peripherally acting \u03bc-opioid receptor antagonist (PAMORAs) for the management of patients with opioid-induced constipation: a systematic review","volume":"13","author":"Rekatsina M","year":"2021","unstructured":"Rekatsina M, Paladini A, Drewes AM, et al.. Efficacy and safety of peripherally acting \u03bc-opioid receptor antagonist (PAMORAs) for the management of patients with opioid-induced constipation: a systematic review. Cureus. 2021, 13:e16201. 10.7759\/cureus.16201","journal-title":"Cureus"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S243435","article-title":"Naldemedine: a new option for OIBD","volume":"13","author":"Coluzzi F","year":"2020","unstructured":"Coluzzi F, Scerpa MS, Pergolizzi J. Naldemedine: a new option for OIBD. J Pain Res. 2020, 13:1209-22. 10.2147\/JPR.S243435","journal-title":"J Pain Res"},{"key":"ref55","article-title":"[Opioid-induced constipation in oncologic patient: a clinical case treated with naloxegol]","volume":"110","author":"Gallo P","year":"2019","unstructured":"Gallo P. [Opioid-induced constipation in oncologic patient: a clinical case treated with naloxegol]. Recenti Prog Med. 2019, 110:6e-9e.","journal-title":"Recenti Prog Med"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0b013e318237d626","article-title":"A multi-institutional study analyzing effect of prophylactic medication for prevention of opioid-induced gastrointestinal dysfunction","volume":"28","author":"Ishihara M","year":"2012","unstructured":"Ishihara M, Ikesue H, Matsunaga H, et al.. A multi-institutional study analyzing effect of prophylactic medication for prevention of opioid-induced gastrointestinal dysfunction. Clin J Pain. 2012, 28:373-81. 10.1097\/AJP.0b013e318237d626","journal-title":"Clin J Pain"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1586\/17474124.2016.1129275","article-title":"The efficacy of standard laxative use for the prevention and treatment of opioid induced constipation during oxycodone use: a small Dutch observational pilot study","volume":"10","author":"Koopmans-Klein G","year":"2016","unstructured":"Koopmans-Klein G, Wagemans MF, Wartenberg HC, Van Megen YJ, Huygen FJ. The efficacy of standard laxative use for the prevention and treatment of opioid induced constipation during oxycodone use: a small Dutch observational pilot study. Expert Rev Gastroenterol Hepatol. 2016, 10:547-53. 10.1586\/17474124.2016.1129275","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-017-0621-2","article-title":"What is polypharmacy? A systematic review of definitions","volume":"17","author":"Masnoon N","year":"2017","unstructured":"Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017, 17:230. 10.1186\/s12877-017-0621-2","journal-title":"BMC Geriatr"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1007\/s41999-021-00479-3","article-title":"Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences","volume":"12","author":"Pazan F","year":"2021","unstructured":"Pazan F, Wehling M. Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences. Eur Geriatr Med. 2021, 12:443-52. 10.1007\/s41999-021-00479-3","journal-title":"Eur Geriatr Med"},{"key":"ref60","article-title":"Polypharmacy: evaluating risks and deprescribing","volume":"100","author":"Halli-Tierney AD","year":"2019","unstructured":"Halli-Tierney AD, Scarbrough C, Carroll D. Polypharmacy: evaluating risks and deprescribing. Am Fam Physician. 2019, 100:32-8.","journal-title":"Am Fam Physician"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain--United States, 2016","volume":"315","author":"Dowell D","year":"2016","unstructured":"Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain--United States, 2016. JAMA. 2016, 315:1624-45. 10.1001\/jama.2016.1464","journal-title":"JAMA"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcl109","article-title":"Escalating polypharmacy","volume":"99","author":"Gorard DA","year":"2006","unstructured":"Gorard DA. Escalating polypharmacy. QJM. 2006, 99:797-800. 10.1093\/qjmed\/hcl109","journal-title":"QJM"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2019.7087","article-title":"Evaluation of a common prescribing cascade of calcium channel blockers and diuretics in older adults with hypertension","volume":"180","author":"Savage RD","year":"2020","unstructured":"Savage RD, Visentin JD, Bronskill SE, et al.. Evaluation of a common prescribing cascade of calcium channel blockers and diuretics in older adults with hypertension. JAMA Intern Med. 2020, 180:643-51. 10.1001\/jamainternmed.2019.7087","journal-title":"JAMA Intern Med"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.3928\/00989134-20190102-01","article-title":"Combating polypharmacy through deprescribing potentially inappropriate medications","volume":"45","author":"Chou J","year":"2019","unstructured":"Chou J, Tong M, Brandt NJ. Combating polypharmacy through deprescribing potentially inappropriate medications. J Gerontol Nurs. 2019, 45:9-15. 10.3928\/00989134-20190102-01","journal-title":"J Gerontol Nurs"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.13702","article-title":"American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adults","volume":"63","year":"2015","unstructured":"American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015, 63.2227-46. 10.1111\/jgs.13702","journal-title":"J Am Geriatr Soc"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.15767","article-title":"American Geriatrics Society 2019 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults","volume":"67","year":"2019","unstructured":"American Geriatrics Society 2019 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019, 67.674-94. 10.1111\/jgs.15767","journal-title":"J Am Geriatr Soc"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2020.1697676","article-title":"STOPP\/START criteria for potentially inappropriate medications\/potential prescribing omissions in older people: origin and progress","volume":"13","author":"O'Mahony D","year":"2020","unstructured":"O'Mahony D. STOPP\/START criteria for potentially inappropriate medications\/potential prescribing omissions in older people: origin and progress. Expert Rev Clin Pharmacol. 2020, 13:15-22. 10.1080\/17512433.2020.1697676","journal-title":"Expert Rev Clin Pharmacol"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1177\/0091270006292126","article-title":"The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity","volume":"46","author":"Carnahan RM","year":"2006","unstructured":"Carnahan RM, Lund BC, Perry PJ, Pollock BG, Culp KR. The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity. J Clin Pharmacol. 2006, 46:1481-6. 10.1177\/0091270006292126","journal-title":"J Clin Pharmacol"},{"key":"ref69","article-title":"Rational deprescribing in the elderly","volume":"31","author":"Williams S","year":"2019","unstructured":"Williams S, Miller G, Khoury R, et al.. Rational deprescribing in the elderly. Ann Clin Psychiatry. 2019, 31:144-52.","journal-title":"Ann Clin Psychiatry"},{"key":"ref70","unstructured":"Pocket Guide. Tapering Opioids for Chronic Pain | CDC. (2018). Accessed: August 2, 2023: https:\/\/www.cdc.gov\/drugoverdose\/pdf\/clinical_pocket_guide_tapering-a.pdf."},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1177\/20451253221082386","article-title":"Experiences with benzodiazepine use, tapering, and discontinuation: an Internet survey","volume":"12","author":"Reid Finlayson AJ","year":"2022","unstructured":"Reid Finlayson AJ, Macoubrie J, Huff C, Foster DE, Martin PR. Experiences with benzodiazepine use, tapering, and discontinuation: an Internet survey. Ther Adv Psychopharmacol. 2022, 12:20451253221082386. 10.1177\/20451253221082386","journal-title":"Ther Adv Psychopharmacol"},{"key":"ref72","unstructured":"Opioid Taper Decision Tool | US Department of Veterans Affairs. (2018). Accessed. August 2, 2023: https:\/\/www.healthquality.va.gov\/guidelines\/Pain\/cot\/VADoDOTCPG022717.pdf."},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2017.06.008","article-title":"\"I'm not gonna pull the rug out from under you\": patient-provider communication about opioid tapering","volume":"18","author":"Matthias MS","year":"2017","unstructured":"Matthias MS, Johnson NL, Shields CG, Bair MJ, MacKie P, Huffman M, Alexander SC. \"I'm not gonna pull the rug out from under you\": patient-provider communication about opioid tapering. J Pain. 2017, 18:1365-73. 10.1016\/j.jpain.2017.06.008","journal-title":"J Pain"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2018.08.010","article-title":"Deprescribing guidelines: an international symposium on development, implementation, research and health professional education","volume":"15","author":"Farrell B","year":"2019","unstructured":"Farrell B, Conklin J, Dolovich L, et al.. Deprescribing guidelines: an international symposium on development, implementation, research and health professional education. Res Social Adm Pharm. 2019, 15:780-9. 10.1016\/j.sapharm.2018.08.010","journal-title":"Res Social Adm Pharm"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-012-2077-6","article-title":"Shared decision making: a model for clinical practice","volume":"27","author":"Elwyn G","year":"2012","unstructured":"Elwyn G, Frosch D, Thomson R, et al.. Shared decision making: a model for clinical practice. J Gen Intern Med. 2012, 27:1361-7. 10.1007\/s11606-012-2077-6","journal-title":"J Gen Intern Med"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.21980\/J8T938","article-title":"Spinal epidural abscess","volume":"5","author":"Luo CT","year":"2020","unstructured":"Luo CT, Yee J. Spinal epidural abscess. J Educ Teach Emerg Med. 2020, 5:S26-52. 10.21980\/J8T938","journal-title":"J Educ Teach Emerg Med"},{"key":"ref77","article-title":"Systematic review of caudal epidural injections in the management of chronic back pain","volume":"96","author":"Dighe G","year":"2013","unstructured":"Dighe G, Friedman JH.. Systematic review of caudal epidural injections in the management of chronic back pain. R I Med J. 2013, 96:12-6.","journal-title":"R I Med J"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1097\/PHM.0000000000000825","article-title":"Distribution patterns of the vulnerable vessels around cervical nerve roots: a computed tomography-based study","volume":"97","author":"Park D","year":"2018","unstructured":"Park D. Distribution patterns of the vulnerable vessels around cervical nerve roots: a computed tomography-based study. Am J Phys Med Rehabil. 2018, 97:242-7. 10.1097\/PHM.0000000000000825","journal-title":"Am J Phys Med Rehabil"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2016.01.014","article-title":"Surgical management and outcome of iatrogenic radial nerve injection injuries","volume":"142","author":"Esquenazi Y","year":"2016","unstructured":"Esquenazi Y, Park SH, Kline DG, Kim DH. Surgical management and outcome of iatrogenic radial nerve injection injuries. Clin Neurol Neurosurg. 2016, 142:98-103. 10.1016\/j.clineuro.2016.01.014","journal-title":"Clin Neurol Neurosurg"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1227\/01.NEU.0000339130.90379.89","article-title":"Upper-extremity peripheral nerve injuries: a Louisiana State University Health Sciences Center literature review with comparison of the operative outcomes of 1837 Louisiana State University Health Sciences Center median, radial, and ulnar nerve lesions","volume":"65","author":"Murovic JA","year":"2009","unstructured":"Murovic JA. Upper-extremity peripheral nerve injuries: a Louisiana State University Health Sciences Center literature review with comparison of the operative outcomes of 1837 Louisiana State University Health Sciences Center median, radial, and ulnar nerve lesions. Neurosurgery. 2009, 65:A11-7. 10.1227\/01.NEU.0000339130.90379.89","journal-title":"Neurosurgery"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2014.20.5.467","article-title":"The prevalence of opioid-related major potential drug-drug interactions and their impact on health care costs in chronic pain patients","volume":"20","author":"Pergolizzi JV Jr","year":"2014","unstructured":"Pergolizzi JV Jr, Ma L, Foster DR, Overholser BR, Sowinski KM, Taylor R Jr, Summers KH. The prevalence of opioid-related major potential drug-drug interactions and their impact on health care costs in chronic pain patients. J Manag Care Spec Pharm. 2014, 20:467-76. 10.18553\/jmcp.2014.20.5.467","journal-title":"J Manag Care Spec Pharm"},{"key":"ref82","unstructured":"FDA. FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering Rockville, Maryland. FDA. (2019). Accessed: August 2, 2023: https:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm635038.htm.."},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1159\/000506868","article-title":"Acute and persistent withdrawal syndromes following discontinuation of psychotropic medications","volume":"89","author":"Cosci F","year":"2020","unstructured":"Cosci F, Chouinard G. Acute and persistent withdrawal syndromes following discontinuation of psychotropic medications. Psychother Psychosom. 2020, 89:283-306. 10.1159\/000506868","journal-title":"Psychother Psychosom"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108664","article-title":"\"I felt like I had a scarlet letter\": recurring experiences of structural stigma surrounding opioid tapers among patients with chronic, non-cancer pain","volume":"222","author":"Benintendi A","year":"2021","unstructured":"Benintendi A, Kosakowski S, Lagisetty P, Larochelle M, Bohnert AS, Bazzi AR. \"I felt like I had a scarlet letter\": recurring experiences of structural stigma surrounding opioid tapers among patients with chronic, non-cancer pain. Drug Alcohol Depend. 2021, 222:108664. 10.1016\/j.drugalcdep.2021.108664","journal-title":"Drug Alcohol Depend"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1186\/s13012-016-0480-9","article-title":"Implementing shared decision-making: consider all the consequences","volume":"11","author":"Elwyn G","year":"2016","unstructured":"Elwyn G, Frosch DL, Kobrin S. Implementing shared decision-making: consider all the consequences. Implement Sci. 2016, 11:114. 10.1186\/s13012-016-0480-9","journal-title":"Implement Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/183818-iatrogenic-side-effects-of-pain-therapies","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:53:52Z","timestamp":1707508432000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/183818-iatrogenic-side-effects-of-pain-therapies"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,2]]},"references-count":85,"URL":"https:\/\/doi.org\/10.7759\/cureus.44583","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,2]]}}}